p. 1−6
2008-2363
Vol.23/No.1
0.05). The diastolic blood pressure during surgery at 5, 10, 15, 20, 25 and 30 minutes after the removal of the baby was significantly less in the phenylephrine group than Ephedrine group (P<0.05). Heart rate of patients during surgery except minutes before spinal anesthesia, 6 min after spinal anesthesia, 40 and 45 after the removal of the newborn was significantly less in the phenylephrine group than ephedrine group (P<0.05). First minute Apgar score was significantly higher in phenylephrine group than the ephedrine group (P<0.05). Fifth minute Apgar score was not significantly different between the two groups (P >0.05). There was no significant difference in the PH of newborns in two groups (P>0.05).
Conclusion: Both ephedrin and phenylephrine can be used in treatment of hypotension due to spinal anesthesia in pregnant women candidate for caesarean section, without any significant differences in control of systemic blood pressure and minimum effect on Apgar score. ]]>
p. 7−18
2008-2363
Vol.23/No.1
p. 19−24
2008-2363
Vol.23/No.1
0.05).
Conclusion: Sleep disorder has high prevalence in pregnant women. Therefore, to improve the sleep quality of pregnant women, in addition to routine prenatal care, a program should be design for diagnosis, etiology and treatment of this disorder.]]>
p. 25−32
2008-2363
Vol.23/No.1
p. 33−39
2008-2363
Vol.23/No.1
p. 40−47
2008-2363
Vol.23/No.1
0.05). There was no significant difference in mean of anthropometric indices between two groups including: total pregnancy weight gain (P = 0.51), third trimester BMI (P = 0.11), BMI (P = 0.19), waist circumference (P = 0.21), systolic (P = 0.22) and diastolic blood pressure (P = 0.34), weight retention (P = 0.37) at postpartum follow-up.
Conclusion: Maternal serum apelin-36 level had negative significant relationship with maternal body mass index and waist circumference in cesarean section group. However, this mechanism is not completely known.]]>
p. 48−57
2008-2363
Vol.23/No.1
p. 58−68
2008-2363
Vol.23/No.1
p. 69−78
2008-2363
Vol.23/No.1
p. 79−87
2008-2363
Vol.23/No.1
0.05). There was no significant relationship between increased prolactin level and breast cancer in menopausal women (p = 0.425). There was no significant relationship between increased prolactin hormone and breast cancer in pre-menopausal women (p = 0.867). There was no significant difference between menopausal women with breast cancer and control group in the frequency of TSH (p = 0.378).
Conclusion: There was no significant relationship between increased prolactin hormone and breast cancer in menopausal and pre-menopausal women. However, elevated serum levels of TSH were more common among those with breast cancer than healthy controls, but the difference was not significant. However, further investigation is needed in this regard.]]>
p. 88−96
2008-2363
Vol.23/No.1
p. 97−100
2008-2363
Vol.23/No.1